| Metric | სს ინოვას | სს ბიოფარმი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.0m₾1.9m | ₾10.1m₾9.7m |
| Revenue growth | 165.0% | 4.8% |
| Profitability | ||
| EBITDA | ₾2.8m₾549k | -₾847k-₾427k |
| EBITDA margin | 56.5%29.1% | -8.3%-4.4% |
| Net profit | ₾2.7m₾378k | -₾1.3m-₾1.1m |
| Net margin | 54.8%20.0% | -12.6%-11.5% |
| Balance sheet | ||
| Total assets | ₾6.3m₾4.0m | ₾19.1m₾18.5m |
| Total equity | ₾5.5m₾3.2m | ₾18.2m₾17.1m |
| ROE | 49.8%11.7% | -7.0%-6.5% |